Animal-Free Pharmaceutical Formulation Development
Zero Animal Biotech is a pre-commercial R&D biotech company developing plant-based formulations for generic medications—free from lactose and animal-derived excipients like magnesium stearate.
The Problem
Lactose intolerant globally
Most hormonal medications contain lactose as an excipient, causing digestive issues for billions worldwide
Avoid animal products for religious reasons
Muslims, Jews, and Hindus concerned about animal-derived ingredients like magnesium stearate
Interested in plant-based options
Growing consumer interest in adding plant-based products, particularly among younger demographics
Our Mission
Develop animal-free formulations for generic medications that eliminate lactose and all animal-derived ingredients, starting with Dienogest for endometriosis treatment.
First Development: Dienogest
A hormonal medication for endometriosis affecting 10% of people with a uterus globally—currently only available with lactose and animal-derived excipients.
Partnership with India
We've partnered with India's largest CDMO to test and validate our plant-based formulations for future licensing to pharmaceutical distributors.
For Investors
Zero Animal Biotech addresses multiple underserved pharmaceutical markets with a single innovative solution
Market Convergence
Our zero animal formulation platform captures three mega-trends simultaneously: lactose-free pharmaceuticals, halal/kosher medical alternatives, and the global plant-based movement.
Global Dienogest Market
Target Patients in Latin America
Animal-Free Competitors
Development
Pre-commercial R&D phase developing plant-based formulations with India's largest CDMO
Licensing Model
License formulations to regulated pharmaceutical distributors—we never engage in direct sales or distribution
Scalable Platform
Expand from Dienogest to other generic medications using our animal-free formulation expertise
Why Zero Animal Biotech
First-Mover Advantage
No existing animal-free formulations for hormonal generics—massive untapped market opportunity
Proven Partnership
Collaboration with India's largest CDMO ensures manufacturing readiness and scalability
Multi-Market Appeal
Single solution serves lactose-intolerant, religious, and plant-based consumer segments
Asset-Light Model
Licensing strategy minimizes capital requirements and regulatory complexity